CVS Health in its appointment of 4 new board members and confidentiality agreement with Glenview Capital Management

The Board of Directors of CVS Health (NYSE: CVS) today announced the appointment of four new board members following productive discussions with Glenview Capital Management.  In connection with the Board appointments, CVS Health and Glenview entered into a confidentiality agreement under which Glenview has agreed to customary confidentiality, standstill and other provisions.

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to CVS Health.